Phase 1 Study of HBN-1
NCT04094857
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Cardiac Arrest
Interventions
DRUG:
HBN-1
Sponsor
Hibernaid, Inc